Skip to main content
. 2014 Jun 18;5(15):6028–6037. doi: 10.18632/oncotarget.2112

Table 1. Cytotoxicity of 4EGI-1 isomers on breast CSCs and breast cancer cells.

BCSCs and breast cancer cells IC50 of [E]-4EGI-1(μM) IC50 of [Z]-4EGI-1(μM)
SKBR-3 30±1.5 29±1.3
MCF-7 30±0.9 30±1.1
MDA-MB-231 32±1.2 30±1.4
Non-BCSCs of HMLER(CD44high/CD24low)SA 24±1.1 22±0.7
BCSCs of HMLER(CD44high/CD24low)FA 11±0.8 10±0.6

Note: IC50 means inhibitory concentration that leads to 50% cell viability decrease.